Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Ali A Alizadehmojarad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. Hauptthemen laut MEDLINE: Glucagon, Diabetes Mellitus, Type 1, Blood Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust.
Abstract (Originalsprache)
Glucose‐responsive glucagon (GRG) therapeutics are a promising technology for reducing the risk of severe hypoglycemia as a complication of diabetes mellitus. Herein, the performance of candidate GRGs in the literature by modeling the kinetics of activation and connecting them as input into physiological glucoregulatory models is evaluated and projected the two distinct GRG designs, experimental results reported in Wu et al. (GRG‐I) and Webber et al. (GRG‐II) is considered. Both are evaluated using a multi‐compartmental glucoregulatory model (IMPACT) and used to compare in‐vivo experimental data of therapeutic performance in rats and mice. For GRG‐I and GRG‐II, the total integrated glucose material balances are overestimated by 41.5% ± 14% and underestimated by 24.8% ± 16% compared to in‐vivo time‐course data, respectively. These large differences to the relatively simple computational descriptions of glucagon dynamics in the model, which underscores the urgent need for improved glucagon models is attributed. Additionally, therapeutic insulin and glucagon infusion pumps are modeled for type 1 diabetes mellitus (T1DM) human subjects to extend the results to additional datasets. These observations suggest that both the representative physiological and non‐physiological models considered in this work require additional refinement to successfully describe clinical data that involve simultaneous, coupled insulin, glucose, and glucagon dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
ORCID-Profile: Michael S Strano
Förderung
- Leona M. and Harry B. Helmsley Charitable Trust
Zitieren
APA
Alizadehmojarad, A. A., Yang, S., Gong, X., & Strano, M. S. (2024). Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401410
Vancouver
Alizadehmojarad AA, Yang S, Gong X, Strano MS. Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401410
BibTeX
@article{Alizadehmojarad2024,
author = {Alizadehmojarad, Ali A and Yang, Sungyun and Gong, Xun and Strano, Michael S},
title = {Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401410}
}
EUVIMED